<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45-microorganisms-08-00085">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Laurens</surname>
    <given-names>M.B.</given-names>
   </name>
   <name>
    <surname>Mungwira</surname>
    <given-names>R.G.</given-names>
   </name>
   <name>
    <surname>Nyirenda</surname>
    <given-names>O.M.</given-names>
   </name>
   <name>
    <surname>Divala</surname>
    <given-names>T.H.</given-names>
   </name>
   <name>
    <surname>Kanjala</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Muwalo</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Mkandawire</surname>
    <given-names>F.A.</given-names>
   </name>
   <name>
    <surname>Tsirizani</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Nyangulu</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Mwinjiwa</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>TSCQ study: A randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: Study protocol for a randomized controlled trial</article-title>
  <source>Trials</source>
  <year>2016</year>
  <volume>17</volume>
  <fpage>322</fpage>
  <pub-id pub-id-type="doi">10.1186/s13063-016-1392-3</pub-id>
  <?supplied-pmid 27431995?>
  <pub-id pub-id-type="pmid">27431995</pub-id>
 </element-citation>
</ref>
